Time for Change in the Conduct of Clinical Trials in Patients with Rheumatoid Arthritis

被引：2
|
作者：
Kremer, Joel M. [1 ]
机构：
[1] Ctr Rheumatol, Albany, NY 12206 USA
来源：
JOURNAL OF RHEUMATOLOGY | 2011年 / 38卷 / 10期
关键词：
D O I：
10.3899/jrheum.110656
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：2087 / 2088
页数：2
相关论文
共 50 条
  • [41] SAFETY OF LEFLUNOMIDE IN RHEUMATOID ARTHRITIS; FROM CLINICAL TRIALS TO CLINICAL PRACTICE
    Hassan, Al
    Galarraga, B.
    Jordan, K. M.
    Armstrong, R. D.
    RHEUMATOLOGY, 2003, 42 : 98 - 98
  • [42] Seronegative rheumatoid arthritis: Neglected in clinical trials, a giant in clinical practice
    Bugatti, Serena
    Montecucco, Carlomaurizio
    JOINT BONE SPINE, 2025, 92 (01)
  • [43] Quantitative measures for assessing rheumatoid arthritis in clinical trials and clinical care
    Pincus, T
    Sokka, T
    BEST PRACTICE & RESEARCH IN CLINICAL RHEUMATOLOGY, 2003, 17 (05): : 753 - 781
  • [44] GASTROINTESTINAL SAFETY OF TOCILIZUMAB: DATA FROM PATIENTS WITH RHEUMATOID ARTHRITIS IN ROCHE CLINICAL TRIALS AND CLINICAL PRACTICE
    Van Vollenhoven, Ronald
    Keystone, Edward
    Furie, Richard
    Blesch, Anne
    Wang, Candace D.
    Curtis, Jeffrey R.
    RHEUMATOLOGY, 2010, 49 : I103 - I103
  • [45] Patients with rheumatoid arthritis in clinical care
    Smolen, JS
    Aletaha, D
    ANNALS OF THE RHEUMATIC DISEASES, 2004, 63 (03) : 221 - 225
  • [46] Adalimumab safety in Crohn's disease and rheumatoid arthritis clinical trials, reduced mortality in rheumatoid arthritis
    Burmester, G. R.
    Panaccione, R.
    Kent, J. D.
    Pangan, A. L.
    AMERICAN JOURNAL OF GASTROENTEROLOGY, 2006, 101 (09): : S452 - S453
  • [47] Meta-Analysis of the Time Course of the Response to Adalimumab Plus Methotrexate or Methotrexate Monotherapy in Clinical Trials of Patients with Rheumatoid Arthritis
    Wang, Xin
    Kavanaugh, Arthur
    van der Heijde, Desiree
    Dougados, Maxime
    Florentinus, Stefan
    Li, Yihan
    Sainsbury, Iain
    Smolen, Josef S.
    ARTHRITIS & RHEUMATOLOGY, 2015, 67
  • [48] Underpowered clinical trials: Time for a change
    van Kleef, Maarten
    Kessels, Alfons G. H.
    PAIN, 2009, 145 (03) : 265 - 266
  • [49] Malignancies in rheumatoid arthritis (RA) clinical trials with adalimumab (HUMIRATM).
    Schiff, MH
    Gelhorn, AJ
    Chartash, E
    Fischkoff, SA
    ARTHRITIS AND RHEUMATISM, 2003, 48 (09): : S700 - S700
  • [50] Issues in the design of new clinical trials for rheumatoid arthritis therapeutics
    William D Schwieterman
    Nature Clinical Practice Rheumatology, 2008, 4 : 641 - 648
12345